SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-19-031539
Filing Date
2019-08-12
Accepted
2019-08-12 17:26:30
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 flgt-s3.htm S-3 498542
2 EX-4.4 flgt-ex44_19.htm EX-4.4 625564
3 EX-4.5 flgt-ex45_18.htm EX-4.5 566818
4 EX-5.1 flgt-ex51_17.htm EX-5.1 50955
5 EX-23.1 flgt-ex231_16.htm EX-23.1 2798
6 GRAPHIC g4icvx3alhww000001.jpg GRAPHIC 2450
7 GRAPHIC g4icvx3alhww000002.jpg GRAPHIC 3145
8 GRAPHIC gouu3bvxhc3x000001.jpg GRAPHIC 2765
9 GRAPHIC gouu3bvxhc3x000002.jpg GRAPHIC 3772
  Complete submission text file 0001564590-19-031539.txt   1763091
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

IRS No.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-233227 | Film No.: 191017559
SIC: 8071 Services-Medical Laboratories